Calcium signalling of human pluripotent stem cell-derived cardiomyocytes

Journal of Physiology

Volumn 591, Issue 21, 2013, Pages 5279-5290

  Li, Sen ^a,b   Chen, Gaopeng ^a,b   Li, Ronald A ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL L TYPE; CALSEQUESTRIN; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN;

BLASTOCYST; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARDIOTOXICITY; CELL HETEROGENEITY; CELL MATURATION; CELL RENEWAL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; INNER CELL MASS; MORULA; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM;

CALCIUM SIGNALING; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC;

EID: 84886778845     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.256495     Document Type: Review

References (90)

1. Anderson D, Self T, Mellor IR, Goh G, Hill SJ & Denning C (2007). Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 15, 2027-2036.
2. Awasthi S, Matthews DL, Li RA, Chiamvimonvat N, Lieu DK & Chan JW (2012). Label-free identification and characterization of human pluripotent stem cell-derived cardiomyocytes using second harmonic generation (SHG). J Microscopy Biophoton 5, 57-66.
3. Bassani JWM, Yuan WL & Bers DM (1995). Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol Cell Physiol 268, C1313-C1319.
4. Beard NA, Laver DR & Dulhunty AF (2004). Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 85, 33-69.
5. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415, 198-205.
6. Brette F & Orchard C (2003). T-tubule function in mammalian cardiac myocytes. Circ Res 92, 1182-1192.
7. Brette F & Orchard C (2007). Resurgence of cardiac T-tubule research. Physiology 22, 167-173.
8. Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan XA, Peters A, Mahairaki V, Koliatsos VE, Tung L & Zambidis ET (2011). A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 6, e18293.
9. Chan JW, Lieu DK, Huser T & Li RA (2009). Label-free separation of human embryonic stem cells and their cardiac derivatives using raman spectroscopy. Anal Chem 81, 1324-1331.
10. 2+ sparks. Cell Calcium 20, 129-140.
11. Cheng H, Lederer WJ & Cannell MB (1993). Calcium sparks - elementary events underlying excitation-contraction coupling in heart-muscle. Science 262, 740-744.
12. Cheng HP & Lederer WJ (2008). Calcium sparks. Physiol Rev 88, 1491-1545.
13. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24, 236-245.
14. Evans MJ & Kaufman MH (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
15. 2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. Stem Cells Dev 19, 773-782.
16. 2+ transients and contraction in cardiomyocytes derived from embryonic stem cells. FASEB J 20, 181-183.
17. Fu JD, Yu HM, Wang R, Liang J & Yang HT (2006b). Developmental regulation of intracellular calcium transients during cardiomyocyte differentiation of mouse embryonic stem cells. Acta Pharmacol Sin 27, 901-910.
18. 2 subunit of L-type voltage-dependent calcium channels. Biochemistry 38, 10361-10370.
19. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS & Zhang K (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67.
20. Guan K, Wagner S, Unsold B, Maier LS, Kaiser D, Hemmerlein B, Nayernia K, Engel W & Hasenfuss G (2007). Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 100, 1615-1625.
21. Gyorke I, Hester N, Jones LR & Gyorke S (2004). The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 86, 2121-2128.
22. Halbach M, Pfannkuche K, Pillekamp F, Ziomka A, Hannes T, Reppel M, Hescheler J & Muller-Ehmsen J (2007). Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res 101, 484-492.
23. He JQ, Ma Y, Lee Y, Thomson JA & Kamp TJ (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes - Action potential characterization. Circ Res 93, 32-39.
24. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W & Melton DA (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26, 1269-1275.
25. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gepstein A, Habib M, Yankelson L, Kehat I & Gepstein L (2007). Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 21, 2551-2563.
26. Itzhaki I, Maizels L, Huber I, Gepstein A, Arbel G, Caspi O, Miller L, Belhassen B, Nof E, Glikson M & Gepstein L (2012). Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol 60, 990-1000.
27. Itzhaki I, Rapoport S, Huber I, Mizrahi I, Zwi-Dantsis L, Arbel G, Schiller J, Gepstein L (2011). Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6, e18037.
28. Itzhaki I, Schiller J, Beyar R, Satin J & Gepstein L (2006). Calcium handling in embryonic stem cell-derived cardiac myocytes - of mice and men. Ann N Y Acad Sci 1080, 207-215.
29. Izu LT, Wier WG & Balke CW (2001). Evolution of cardiac calcium waves from stochastic calcium sparks. Biophys J 80, 103-120.
30. 2+ signalling in developing cardiac cells. Ann N Y Acad Sci 1080, 154-164.
31. Jung CB, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, Dorn T, Ruppenthal S, Pfeiffer S, Goedel A, Dirschinger RJ, Seyfarth M, Lam JT, Sinnecker D, Gudermann T, Lipp P & Laugwitz K-L (2012). Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 4, 180-191.
32. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J & Keller G (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240.
33. Kehat I, Gepstein A, Spira A, Itskovitz-Eldor J & Gepstein L (2002). High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 91, 659-661.
34. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J & Gepstein L (2001). Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 407-414.
35. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J & Gepstein L (2004). Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22, 1282-1289.
36. 2+ sparks. Biophys J 75, 595-600.
37. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M & Scholer HR (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646-650
38. Kong CW, Akar FG & Li RA (2010). Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models. Thromb Haemost 104, 30-38.
39. Kujala K, Paavola J, Lahti A, Larsson K, Pekkanen-Mattila M, Viitasalo M, Lahtinen AM, Toivonen L, Kontula K, Swan H, Laine M, Silvennoinen O & Aalto-Setala K (2012). Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS One 7, e446600.
40. Kunst G, Kress KR, Gruen M, Uttenweiler D, Gautel M & Fink RHA (2000). Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res 86, 51-58.
41. Lian XJ, Hsiao C, Wilson G, Zhu KX, Hazeltine LB, Azarin SM, Raval KK, Zhang JH, Kamp TJ & Palecek SP (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalling. Proc Natl Acad Sci U S A 109, E1848-E1857.
42. Lieu DK, Fu J-D, Chiamvimonvat N, Tung KWC, McNerney GP, Huser T, Keller G, Kong C-W & Li RA (2012). Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 6, 191-201.
43. 2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells and Development 18, 1493-1500.
44. Liu J, Fu JD, Siu CW & Li RA (2007). Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: Insights for driven maturation. Stem Cells 25, 3038-3044.
45. 2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. American Journal of Physiology-Cell Physiology 297, C152-C159.
46. 2+ release in human failing cardiomyocytes. Cardiovasc Res 62, 63-73.
47. Lukyanenko V, Gyorke I & Gyorke S (1996). Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflugers Arch 432, 1047-1054.
48. Lundy SD, Zhu W-Z, Regnier M & Laflamme MA (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22, 1991-2002.
49. MacLennan DH & Kranias EG (2003). Phospholamban: A crucial regulator of cardiac contractility. Nature Rev Mol Cell Biol 4, 566-577.
50. Martin GR (1981). Isolation of a pluripotent cell-line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem-cells. Proc Nat Acad Sci U S A 78, 7634-7638.
51. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N & Marks AR (2000). PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 101, 365-376.
52. Meissner A, Wernig M & Jaenisch R (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25, 1177-1181.
53. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP & Duboc D (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41, 1078-1083.
54. Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S, Kadota S, Morone N, Barve M, Asai Y, Tenkova-Heuser T, Heuser JE, Uesugi M, Aiba K & Nakatsuji N (2012). A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep 2, 1448-1460.
55. Moore JC, Fu JD, Chan YC, Lin DW, Tran H, Tse HF & Li RA (2008). Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun 372, 553-558.
56. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KBS, Ismail Virag J, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA & Field LJ (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668.
57. Musunuru K, Domian IJ & Chien KR (2010). Stem cell models of cardiac development and disease. Annu Rev Cell Dev Biol 26, 667-687.
58. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N & Yamanaka S (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26, 101-106.
59. Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, Lorber A, Itskovitz-Eldor J & Binah O (2012). Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation. J Cell Mol Med 16, 468-482.
60. Pillekamp F, Haustein M, Khalil M, Emmelheinz M, Nazzal R, Adelmann R, Nguemo F, Rubenchyk O, Pfannkuche K, Matzkies M, Reppel M, Bloch W, Brockmeier K & Hescheler J (2012). Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. Stem Cells Dev 21, 2111-2121.
61. Poon E, Kong CW & Li RA (2011). Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Mol Pharm 8, 1495-1504.
62. Ren Y, Lee MY, Schliffke S, Paavola J, Amos PJ, Ge X, Ye M, Zhu S, Senyei G, Lum L, Ehrlich BE & Qyang Y (2011). Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol 51, 280-287.
63. Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E & Jaconi ME (2007). Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25, 1136-1144.
64. Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G, Beyar R, Balke CW, Schiller J & Gepstein L (2008). Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26, 1961-1972.
65. Sauer H, Theben T, Hescheler JR, Lindner M, Brandt MC & Wartenberg M (2001). Characteristics of calcium sparks in cardiomyocytes derived from embryonic stem cells. Am J Physiol Heart Circ Physiol 281, H411-H421.
66. 2+ stores and angiotensin-II/endothelin-1 signaling pathway are functional in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26, 3130-3138.
67. Shannon TR, Ginsburg KS & Bers DM (2000). Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J 78, 334-343.
68. Shiba Y, Fernandes S, Zhu W-Z, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE & Laflamme MA (2012). Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325.
69. Sil AK, Maeda S, Sano Y, Roop DR & Karin M (2004). IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428, 660-664.
70. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP & Serruys PW (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42, 2063-2069.
71. Song LS, Guatimosim S, Gomez-Viquez L, Sobie EA, Ziman A, Hartmann H & Lederer WJ (2005). Calcium biology of the transverse tubules in heart. Ann N Y Acad Sci 1047, 99-111.
72. Sulakhe PV & Vo XT (1995). Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic roles of cyclic-nucleotides, calcium, protein-kinases and phosphatases and depolarization. Mol Cell Biochem 149, 103-126.
73. Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ, Navarrete EG, Hu S, Wang L, Lee A, Pavlovic A, Lin S, Chen R, Hajjar RJ, Snyder MP, Dolmetsch RE, Butte MJ, Ashley EA, Longaker MT, Robbins RC & Wu JC (2012). Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4, 130ra147-130ra147.
74. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K & Yamanaka S (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
75. Takahashi K & Yamanaka S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
76. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS & Jones JM (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
77. Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee J-J, Xie C, Senyei G, Li RA, Akar FG, Hajjar RJ, Hulot J-S & Costa KD (2013). Human engineered cardiac tissues from embryonic stem cell derived cardiomyocytes show advanced structure and function. FASEB J (in press).
78. Wang J, Chen A, Lieu DK, Karakikes I, Chen G, Keung W, Chan CW, Hajjar RJ, Costa KD, Khine M & Li RA (2013). Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. Biomaterials 34, 8878-8886.
79. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM & Rossi DJ (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630.
80. Xu CH, Police S, Rao N & Carpenter MK (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91, 501-508.
81. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF & Li RA (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes - Insights into the development of cell-based pacemakers. Circulation 111, 11-20.
82. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ & Keller GM (2008). Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population. Nature 453, 524-526.
83. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin, II & Thomson JA (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
84. Zhang J, Klos M, Wilson GF, Herman AM, Lian X, Raval KK, Barron MR, Hou L, Soerens AG, Yu J, Palecek SP, Lyons GE, Thomson JA, Herron TJ, Jalife J & Kamp TJ (2012). Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells the matrix sandwich method. Circ Res 111, 1125-1178.
85. Zhang L, Kelley J, Schmeisser G, Kobayashi YM & Jones LR (1997). Complex formation between junction, triadin, calsequestrin, and the ryanodine receptor - Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 272, 23389-23397.
86. Zhang ZY, Zhou B & Xie LP (2002). Modulation of protein kinase signalling by protein phosphatases and inhibitors. Pharmacol Ther 93, 307-317.
87. Zhao T, Zhang ZN, Rong Z & Xu Y (2011). Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215.
88. 1-subunit of skeletal-muscle L-type Ca channels is the key target for regulation by A-kinase and protein phosphatase-1C. Biochem Biophys Res Commun 198, 166-173.
89. Zhu WZ, Santana LF & Laflamme MA (2009). Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 4, e5407.
90. Zhu WZ, Xie Y, Moyes KW, Gold JD, Askari B & Laflamme MA (2010). Neuregulin/ErbB signalling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res 107, 776-786.